HOME >> BIOLOGY >> NEWS
Elusive salamanders have role in developing new sampling models

OAK RIDGE, Tenn., June 1, 2005 Rare salamanders at a Georgia military base are the guinea pigs for Oak Ridge National Laboratory researchers whose goal is to develop methods to better determine whether a species has vanished.

After not finding any flatwoods salamanders since 2001, Fort Stewart biologists were a bit concerned and were looking for a better survey method, said Mark Bevelhimer, an aquatic ecologist and member of ORNL's Environmental Sciences Division. A Strategic Environmental Research and Development Program project is helping in that area and addressing even greater challenges.

"Just because you don't see any of the specific species you are looking for doesn't mean they aren't there," Bevelhimer said. "So for us, our task is to develop a method to make field sampling techniques more accurate and efficient. With that information, we can improve our models, and we should be able to do a better job of predicting the type and location of suitable habitats plus minimize unnecessary and time-consuming sampling."

Of more than 1,000 seasonal ponds at the 280,000-acre military facility in southeastern Georgia, 483 have been identified as potential candidates to support this particular salamander, technically known as Ambystoma cingulatum. Until April 21, however, none had been found over a stretch that spanned four years. Researchers noted that this was not totally unexpected because of a 100-year drought event that dried ponds and halted reproduction from 1999 through 2002. Since the first salamander was found six weeks ago, 36 more have been found in one pond, but none in 11 others that have supported them in the past.

In the United States, flatwoods salamanders are found only in Florida, South Carolina and Georgia. The adults lay their eggs in wetland depressions in the late fall. With winter rains, the ponds rise and the eggs hatch in December, January and February. Larval development lasts through May. The larvae then unde
'"/>

Contact: Ron Walli
wallira@ornl.gov
865-576-0226
DOE/Oak Ridge National Laboratory
1-Jun-2005


Page: 1 2 3

Related biology news :

1. Elusive rust resistance genes located
2. Elusive HIV shape change revealed; Key clue to how virus infects cells
3. Pediatric ritalin use may affect developing brain, new study suggests
4. Antibody-altering protein found in developing B cells
5. Spousal choices can influence the risk of developing alcoholism
6. Obtaining valid consent for doing large genetic studies in developing countries
7. Cheaper, better disease treatments expected from faster approach to developing antibodies
8. Study challenges idea that schizophrenia is distinct in developing and developed regions
9. RIT researchers developing micropump for hearing-loss treatments
10. A form of the alcohol dehydrogenase gene may protect Afro-Trinidadians from developing alcoholism
11. Mayo researcher discovers target site for developing mosquito pesticides

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Elusive salamanders have role developing new sampling models

(Date:12/10/2014)...  Valencell, a leader in performance biometric data sensor ... from its licensees for highly accurate, clinically validated biometric ... coming from fitness and health sectors, but first responders/military ... is only as useful as the biometric data it ... in long-term mass consumer adoption of wearable products," said ...
(Date:12/5/2014)... Calif. , Dec. 4, 2014 ... has boosted investments in new testing and inspection ... also given rise to a range of innovative ... the requirements of Generation Y, which is generally ... As a result, product development strategies of test ...
(Date:11/21/2014)... 18, 2014 According to a ... Systems (Video, RFID, Access Control, Intrusion Detection, Parking Management, ... Government), Component Service Geography - Global Forecasts to 2020", ... projected to be around $25 Billion in 2014 and ... at a CAGR of 8.69%. Browse 116 ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... 17, 2014 This report is ... Tubing industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry has witnessed rapid development with key ... acquisitions. This report mentions quartz tubing upstream raw ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
Cached News: